{
    "2021-03-01": [
        [
            {
                "time": "",
                "original_text": "君实生物牵手阿斯利康扩销路三款抗癌药进医保目录降价超70%国产PD-1提速出海",
                "features": {
                    "keywords": [
                        "君实生物",
                        "阿斯利康",
                        "抗癌药",
                        "医保目录",
                        "降价",
                        "PD-1",
                        "出海"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "原料药中的“恒瑞医药”！力压国内同行，PK印度药企",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "原料药",
                        "印度药企",
                        "竞争"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业报告：医药板块大幅调整之后的布局思路",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业报告",
                        "板块调整",
                        "布局思路"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "坤坤还好吗？遇涨“封神”遇跌“脱粉”",
                "features": {
                    "keywords": [
                        "坤坤",
                        "基金",
                        "涨跌",
                        "粉丝"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "",
                "original_text": "抱团股大反攻！ 3200只A股飘红，券商一哥却跌8%",
                "features": {
                    "keywords": [
                        "抱团股",
                        "反攻",
                        "A股",
                        "券商",
                        "下跌"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "东吴证券---医药生物行业：新冠疫苗逐步获批，巨大期权有望加速兑现【行业研究】",
                "features": {
                    "keywords": [
                        "东吴证券",
                        "医药生物",
                        "新冠疫苗",
                        "期权",
                        "加速兑现"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "A股早报2021年3月1日星期一",
                "features": {
                    "keywords": [
                        "A股",
                        "早报",
                        "日期"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-26",
                "original_text": "A股融资融券日报：两融余额减少103.02亿元（2月26日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "减少"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "兼论21年3月十大关注标的：流动性市场后半程 股市再平衡",
                "features": {
                    "keywords": [
                        "流动性",
                        "股市",
                        "平衡",
                        "关注标的"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}